Shiro Mita
Fundador en M's Science Corp. .
Cargos activos de Shiro Mita
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
M's Science Corp.
 M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Director/Miembro de la Junta | 01/11/2000 | - |
| Fundador | 01/11/2000 | - |
Historial de carrera de Shiro Mita
Antiguos cargos conocidos de Shiro Mita.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Director/Miembro de la Junta | 01/03/2016 | - |
| SANTEN PHARMACEUTICAL CO., LTD. | Director/Miembro de la Junta | - | - |
| ACUCELA INC | Director/Miembro de la Junta | 01/05/2015 | - |
| Keio University | Corporate Officer/Principal | - | - |
Formación de Shiro Mita.
| University of Tokyo | Doctorate Degree |
Estadísticas
Internacional
| Japón | 6 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 4 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
| Empresas privadas | 2 |
|---|---|
M's Science Corp.
M's Science Corp. Miscellaneous Commercial ServicesCommercial Services M's Science Corp. engages in the research and development of drugs for the treatment of central nervous system (CNS) disorders and ocular diseases. It develops Cutamesine, an orally active compound that enhances neuroregeneration and facilitates the recovery of damaged CNS tissues from stress or ischemia-induced insults. The firm also develops therapeutic drugs for oncology. The company was founded by Shiro Mita in November 2000 and is headquartered in Kobe, Japan. | Commercial Services |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Shiro Mita
- Experiencia
